Linking calcium to Abeta and Alzheimer's disease - PubMed (original) (raw)

Review

. 2008 Jul 31;59(2):190-4.

doi: 10.1016/j.neuron.2008.07.013.

Affiliations

• PMID: 18667147
• DOI: 10.1016/j.neuron.2008.07.013

Free article

Review

Linking calcium to Abeta and Alzheimer's disease

Kim N Green et al. Neuron. 2008.

Free article

Abstract

Recent developments point to a critical role for calcium dysregulation in the pathogenesis of Alzheimer's disease. A novel calcium-conducting channel called CALHM1 is genetically linked to the disorder and modulates Abeta production. Calcium homeostasis has also been shown to be perturbed in dendritic spines adjacent to amyloid plaques. Finally, new studies have elucidated the role by which presenilins modulate calcium signaling, including effects on SERCA2b and gating of the IP(3) receptor, and lead to Abeta production.

PubMed Disclaimer

Similar articles

• The role of Abeta-induced calcium dysregulation in the pathogenesis of Alzheimer's disease.
  Small DH, Gasperini R, Vincent AJ, Hung AC, Foa L. Small DH, et al. J Alzheimers Dis. 2009;16(2):225-33. doi: 10.3233/JAD-2009-0951. J Alzheimers Dis. 2009. PMID: 19221414 Review.
• Alzheimer's disease: The latest suspect.
  Tanzi RE, Bertram L. Tanzi RE, et al. Nature. 2008 Aug 7;454(7205):706-8. doi: 10.1038/454706a. Nature. 2008. PMID: 18685694 No abstract available.
• Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities.
  Yu JT, Chang RC, Tan L. Yu JT, et al. Prog Neurobiol. 2009 Nov;89(3):240-55. doi: 10.1016/j.pneurobio.2009.07.009. Epub 2009 Aug 5. Prog Neurobiol. 2009. PMID: 19664678 Review.
• Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.
  Kawahara M, Negishi-Kato M, Sadakane Y. Kawahara M, et al. Expert Rev Neurother. 2009 May;9(5):681-93. doi: 10.1586/ern.09.28. Expert Rev Neurother. 2009. PMID: 19402778 Review.
• Alzheimer's disease sends the wrong signals--a perspective.
  Neve RL. Neve RL. Amyloid. 2008 Mar;15(1):1-4. doi: 10.1080/13506120701814608. Amyloid. 2008. PMID: 18266116 Review.

Cited by

• Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review.
  Dailah HG. Dailah HG. Molecules. 2022 Oct 25;27(21):7207. doi: 10.3390/molecules27217207. Molecules. 2022. PMID: 36364033 Free PMC article. Review.
• Exploring the Role of NCX1 and NCX3 in an In Vitro Model of Metabolism Impairment: Potential Neuroprotective Targets for Alzheimer's Disease.
  Preziuso A, Piccirillo S, Cerqueni G, Serfilippi T, Terenzi V, Vinciguerra A, Orciani M, Amoroso S, Magi S, Lariccia V. Preziuso A, et al. Biology (Basel). 2023 Jul 14;12(7):1005. doi: 10.3390/biology12071005. Biology (Basel). 2023. PMID: 37508434 Free PMC article.
• Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ß production.
  Bordji K, Becerril-Ortega J, Nicole O, Buisson A. Bordji K, et al. J Neurosci. 2010 Nov 24;30(47):15927-42. doi: 10.1523/JNEUROSCI.3021-10.2010. J Neurosci. 2010. PMID: 21106831 Free PMC article.
• Regulation of Ryanodine Receptor-Dependent Neurotransmitter Release by AIP, Calstabins, and Presenilins.
  Wang ZW, Niu L, Riaz S. Wang ZW, et al. Adv Neurobiol. 2023;33:287-304. doi: 10.1007/978-3-031-34229-5_11. Adv Neurobiol. 2023. PMID: 37615871
• New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc.
  Corona C, Pensalfini A, Frazzini V, Sensi SL. Corona C, et al. Cell Death Dis. 2011 Jun 23;2(6):e176. doi: 10.1038/cddis.2011.57. Cell Death Dis. 2011. PMID: 21697951 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • GlyGen glycoinformatics resource